Powering a U.S. Launch: Building a Commercial Infrastructure from the Ground Up

European-based client was launching a new innovative FDA-cleared medical device to treat dry eye in the US
They acquired a US-based generics company to allow expansion into the US but had no Commercial infrastructure

We leveraged our breadth of services within Inizio Engage and Propensity4 to support the brand from launch
Hired and trained a team of highly skilled Key Account Managers to launch and sell the product to Ophthalmologists and Optometrists
Built an entire Commercial Operations infrastructure to support the launch and ongoing needs of the client

Built a custom Salesforce.com CRM for the client with a built-in ordering portal
Set up an MDM process to manage the Customer Master end to end (From CRM to Data Warehouse to 3PL and back)
Created an advanced Targeting, Alignment, and Call Plan approach using our propriety Customer Optimizer service
Prepared a launch Most Probable Forecast (MPF) with ongoing operational updates
Developed and implemented a Data Warehouse and Tableau reporting dashboards to allow for weekly performance tracking
Designed and administer Incentive Compensation plan that adapts as the launch progresses
Provide QBR support and strategic guidance

Learn more about our work.

For more case studies and insights from Propensity4, click below.

Jump to a slide with the slide dots.

Join us in welcoming Malea Horn-Attanasio to Propensity4 as our new Decision Science Analyst.

We’re thrilled to announce that Isabelle Amick has joined Propensity4 as our new Senior Director of Data Science!

This blog explores how “bottom-up” forecasting, particularly Most Probable Forecasting (MPF), enhances pharmaceutical brand planning.

Personalized patient engagement boosted therapy adherence with AI-driven insights, risk scoring, and tailored support recommendations.

Accelerating rare disease diagnosis through data-driven patient finding and predictive modeling to connect patients with the right HCPs faster.